Heterosubtypic immunity to influenza type A virus in mice. Effector mechanisms and their longevity - PubMed (original) (raw)
. 1994 Feb 15;152(4):1653-61.
Affiliations
- PMID: 8120375
Heterosubtypic immunity to influenza type A virus in mice. Effector mechanisms and their longevity
S Liang et al. J Immunol. 1994.
Abstract
Immunity that cross-reacts between influenza type A viruses of distinct subtypes is called hetero(sub)typic (Het-I). We have studied Het-I by challenging PR8-immune mice with the heterosubtypic virus X31. Het-I did not prevent infection by X31 but, at its height, strongly aided in recovery. The nature of the effector mechanisms involved was investigated by simultaneous challenge with X31 and an immunologically unrelated influenza type B virus and by depleting individual lymphocyte subsets in PR8-immune mice before challenge. The study showed the following: 1) The effector mechanisms were intimately associated with immune recognition events. 2) In the nose, depletion of CD8+ or CD4+ T cells led to partial reduction of Het-I, and simultaneous depletion of both T cell subsets abrogated Het-I almost completely. This T cell-mediated immunity was short lived and had disappeared 4 to 5 mo after induction. 3) In trachea and lung, depletion of CD8+ T cells led to a partial reduction of Het-I, whereas depletion of CD4+ T cells was without significant effect. The CD8-mediated component appeared short lived, whereas the residual immunity (in CD4/8-depleted mice) was long lived and persisted past 7 mos after induction. 4) Depletion of NK cells did not significantly reduce the strength of Het-I in either nose or lung. In conclusion, the study shows that Het-I in this system is mediated by a complex combination of immune mechanisms that differ, in part, between upper and lower respiratory tract.
Similar articles
- Mechanisms of heterosubtypic immunity to lethal influenza A virus infection in fully immunocompetent, T cell-depleted, beta2-microglobulin-deficient, and J chain-deficient mice.
Epstein SL, Lo CY, Misplon JA, Lawson CM, Hendrickson BA, Max EE, Subbarao K. Epstein SL, et al. J Immunol. 1997 Feb 1;158(3):1222-30. J Immunol. 1997. PMID: 9013963 - Mechanism of protective immunity against influenza virus infection in mice without antibodies.
Epstein SL, Lo CY, Misplon JA, Bennink JR. Epstein SL, et al. J Immunol. 1998 Jan 1;160(1):322-7. J Immunol. 1998. PMID: 9551987 - Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function.
Sambhara S, Kurichh A, Miranda R, Tumpey T, Rowe T, Renshaw M, Arpino R, Tamane A, Kandil A, James O, Underdown B, Klein M, Katz J, Burt D. Sambhara S, et al. Cell Immunol. 2001 Aug 1;211(2):143-53. doi: 10.1006/cimm.2001.1835. Cell Immunol. 2001. PMID: 11591118 - Defense mechanisms against influenza virus infection in the respiratory tract mucosa.
Tamura S, Kurata T. Tamura S, et al. Jpn J Infect Dis. 2004 Dec;57(6):236-47. Jpn J Infect Dis. 2004. PMID: 15623947 Review. - Mechanisms of mouse T lymphocyte-induced suppression of the IgG2ab allotype and T lymphocyte tolerance to IgG2ab.
Majlessi L, Bordenave G. Majlessi L, et al. Arch Immunol Ther Exp (Warsz). 2001;49(6):407-15. Arch Immunol Ther Exp (Warsz). 2001. PMID: 11814234 Review.
Cited by
- Influenza infection fortifies local lymph nodes to promote lung-resident heterosubtypic immunity.
Paik DH, Farber DL. Paik DH, et al. J Exp Med. 2021 Jan 4;218(1):e20200218. doi: 10.1084/jem.20200218. J Exp Med. 2021. PMID: 33005934 Free PMC article. - Infection of the upper respiratory tract with seasonal influenza A(H3N2) virus induces protective immunity in ferrets against infection with A(H1N1)pdm09 virus after intranasal, but not intratracheal, inoculation.
Bodewes R, Kreijtz JH, van Amerongen G, Hillaire ML, Vogelzang-van Trierum SE, Nieuwkoop NJ, van Run P, Kuiken T, Fouchier RA, Osterhaus AD, Rimmelzwaan GF. Bodewes R, et al. J Virol. 2013 Apr;87(8):4293-301. doi: 10.1128/JVI.02536-12. Epub 2013 Jan 30. J Virol. 2013. PMID: 23365444 Free PMC article. - Prospects for universal influenza virus vaccine.
Gerhard W, Mozdzanowska K, Zharikova D. Gerhard W, et al. Emerg Infect Dis. 2006 Apr;12(4):569-74. doi: 10.3201/eid1204.051020. Emerg Infect Dis. 2006. PMID: 16704803 Free PMC article. - Cellular immunity and memory to respiratory virus infections.
Woodland DL, Hogan RJ, Zhong W. Woodland DL, et al. Immunol Res. 2001;24(1):53-67. doi: 10.1385/IR:24:1:53. Immunol Res. 2001. PMID: 11485209 Review. - CC chemokine receptor 7 expression by effector/memory CD4+ T cells depends on antigen specificity and tissue localization during influenza A virus infection.
Debes GF, Bonhagen K, Wolff T, Kretschmer U, Krautwald S, Kamradt T, Hamann A. Debes GF, et al. J Virol. 2004 Jul;78(14):7528-35. doi: 10.1128/JVI.78.14.7528-7535.2004. J Virol. 2004. PMID: 15220427 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous